Verona Pharma plc (VRNA) Misses Q2 EPS by 6c

Verona Pharma plc (NASDAQ: VRNA) reported Q2 EPS of ($0.11), $0.06 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• ACM Research, Inc. (ACMR) PT Raised to $130 at Morgan Stanley
• Qualcomm (QCOM) June 26 weekly 200 and 230 calls active into investor meeting